SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '1og3'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1DDR_B_MTXB200_1 (DIHYDROFOLATE REDUCTASE)	1og3	T-CELL ECTO-ADP-RIBOSYLTRAN SFERASE 2 (Rattus norvegicus)	5 / 12	ALA A 104 ASP A 36 PHE A 100 ARG A 88 TYR A 18	None	1.11A	1ddrB-1og3A: undetectable	1ddrB-1og3A: 23.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1RMT_A_ADNA1501_1 (CLASS B ACID PHOSPHATASE)	1og3	T-CELL ECTO-ADP-RIBOSYLTRAN SFERASE 2 (Rattus norvegicus)	5 / 10	PHE A 142 TYR A 198 LEU A 211 THR A 128 ARG A 126	None None None None NAD A1227 (-3.2A)	1.46A	1rmtA-1og3A: 0.0	1rmtA-1og3A: 21.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1TDR_A_MTXA170_1 (TELLUROMETHIONYL DIHYDROFOLATE REDUCTASE)	1og3	T-CELL ECTO-ADP-RIBOSYLTRAN SFERASE 2 (Rattus norvegicus)	5 / 12	ALA A 104 ASP A 36 PHE A 100 ARG A 88 TYR A 18	None	1.20A	1tdrA-1og3A: undetectable	1tdrA-1og3A: 24.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1X70_B_715B801_2 (DIPEPTIDYL PEPTIDASE IV)	1og3	T-CELL ECTO-ADP-RIBOSYLTRAN SFERASE 2 (Rattus norvegicus)	3 / 3	PHE A 145 TYR A 18 TYR A 107	None	1.05A	1x70B-1og3A: undetectable	1x70B-1og3A: 15.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XVA_A_SAMA293_0 (GLYCINE N-METHYLTRANSFERASE)	1og3	T-CELL ECTO-ADP-RIBOSYLTRAN SFERASE 2 (Rattus norvegicus)	5 / 12	THR A 146 VAL A 90 SER A 219 GLY A 175 TYR A 198	None	1.38A	1xvaA-1og3A: undetectable	1xvaA-1og3A: 22.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2C8A_A_NCAA1252_0 (MONO-ADP-RIBOSYLTRAN SFERASE C3)	1og3	T-CELL ECTO-ADP-RIBOSYLTRAN SFERASE 2 (Rattus norvegicus)	4 / 7	SER A 147 SER A 149 PHE A 160 GLN A 187	NAD A1227 (-3.1A) None NAD A1227 (-3.4A) NAD A1227 (-3.9A)	1.25A	2c8aA-1og3A: 11.4	2c8aA-1og3A: 20.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WRK_D_CAMD502_0 (CAMPHOR 5-MONOOXYGENASE)	1og3	T-CELL ECTO-ADP-RIBOSYLTRAN SFERASE 2 (Rattus norvegicus)	4 / 5	LEU A 113 GLY A 175 THR A 172 VAL A 124	None	0.93A	3wrkD-1og3A: undetectable	3wrkD-1og3A: 19.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EM2_A_SALA504_1 (UNCHARACTERIZED HTH-TYPE TRANSCRIPTIONAL REGULATOR SAR2349)	1og3	T-CELL ECTO-ADP-RIBOSYLTRAN SFERASE 2 (Rattus norvegicus)	4 / 8	PHE A 67 GLY A 72 LEU A 75 ILE A 57	None	0.80A	4em2A-1og3A: undetectable	4em2A-1og3A: 20.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4OTW_A_DB8A1101_2 (RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3)	1og3	T-CELL ECTO-ADP-RIBOSYLTRAN SFERASE 2 (Rattus norvegicus)	3 / 3	LEU A 75 LEU A 43 ASN A 87	None None NAD A1227 (-4.5A)	0.68A	4otwA-1og3A: undetectable	4otwA-1og3A: 20.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVP_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	1og3	T-CELL ECTO-ADP-RIBOSYLTRAN SFERASE 2 (Rattus norvegicus)	5 / 12	SER A 147 GLN A 144 ALA A 155 GLY A 127 THR A 128	NAD A1227 (-3.1A) NAD A1227 (-3.3A) NAD A1227 ( 4.0A) NAD A1227 (-3.7A) None	1.09A	4qvpH-1og3A: undetectable 4qvpI-1og3A: undetectable	4qvpH-1og3A: 22.90 4qvpI-1og3A: 25.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVP_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	1og3	T-CELL ECTO-ADP-RIBOSYLTRAN SFERASE 2 (Rattus norvegicus)	5 / 12	SER A 147 GLN A 144 ALA A 155 GLY A 127 THR A 128	NAD A1227 (-3.1A) NAD A1227 (-3.3A) NAD A1227 ( 4.0A) NAD A1227 (-3.7A) None	1.09A	4qvpV-1og3A: undetectable 4qvpW-1og3A: undetectable	4qvpV-1og3A: 22.90 4qvpW-1og3A: 25.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVV_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2)	1og3	T-CELL ECTO-ADP-RIBOSYLTRAN SFERASE 2 (Rattus norvegicus)	5 / 11	SER A 147 GLN A 144 ALA A 155 GLY A 127 THR A 128	NAD A1227 (-3.1A) NAD A1227 (-3.3A) NAD A1227 ( 4.0A) NAD A1227 (-3.7A) None	1.16A	4qvvH-1og3A: undetectable	4qvvH-1og3A: 22.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVV_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2)	1og3	T-CELL ECTO-ADP-RIBOSYLTRAN SFERASE 2 (Rattus norvegicus)	5 / 11	SER A 147 THR A 146 GLN A 144 ALA A 155 GLY A 127	NAD A1227 (-3.1A) None NAD A1227 (-3.3A) NAD A1227 ( 4.0A) NAD A1227 (-3.7A)	0.97A	4qvvH-1og3A: undetectable	4qvvH-1og3A: 22.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVV_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2)	1og3	T-CELL ECTO-ADP-RIBOSYLTRAN SFERASE 2 (Rattus norvegicus)	5 / 11	SER A 147 GLN A 144 ALA A 155 GLY A 127 THR A 128	NAD A1227 (-3.1A) NAD A1227 (-3.3A) NAD A1227 ( 4.0A) NAD A1227 (-3.7A) None	1.16A	4qvvV-1og3A: undetectable	4qvvV-1og3A: 22.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVV_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2)	1og3	T-CELL ECTO-ADP-RIBOSYLTRAN SFERASE 2 (Rattus norvegicus)	5 / 11	SER A 147 THR A 146 GLN A 144 ALA A 155 GLY A 127	NAD A1227 (-3.1A) None NAD A1227 (-3.3A) NAD A1227 ( 4.0A) NAD A1227 (-3.7A)	0.96A	4qvvV-1og3A: undetectable	4qvvV-1og3A: 22.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVY_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2)	1og3	T-CELL ECTO-ADP-RIBOSYLTRAN SFERASE 2 (Rattus norvegicus)	5 / 11	SER A 147 GLN A 144 ALA A 155 GLY A 127 THR A 128	NAD A1227 (-3.1A) NAD A1227 (-3.3A) NAD A1227 ( 4.0A) NAD A1227 (-3.7A) None	1.15A	4qvyH-1og3A: undetectable	4qvyH-1og3A: 22.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVY_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2)	1og3	T-CELL ECTO-ADP-RIBOSYLTRAN SFERASE 2 (Rattus norvegicus)	5 / 11	SER A 147 THR A 146 GLN A 144 ALA A 155 GLY A 127	NAD A1227 (-3.1A) None NAD A1227 (-3.3A) NAD A1227 ( 4.0A) NAD A1227 (-3.7A)	0.98A	4qvyH-1og3A: undetectable	4qvyH-1og3A: 22.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVY_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	1og3	T-CELL ECTO-ADP-RIBOSYLTRAN SFERASE 2 (Rattus norvegicus)	5 / 12	SER A 147 GLN A 144 ALA A 155 GLY A 127 THR A 128	NAD A1227 (-3.1A) NAD A1227 (-3.3A) NAD A1227 ( 4.0A) NAD A1227 (-3.7A) None	1.15A	4qvyV-1og3A: undetectable 4qvyW-1og3A: undetectable	4qvyV-1og3A: 22.90 4qvyW-1og3A: 25.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QW0_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	1og3	T-CELL ECTO-ADP-RIBOSYLTRAN SFERASE 2 (Rattus norvegicus)	5 / 11	SER A 147 GLN A 144 ALA A 155 GLY A 127 THR A 128	NAD A1227 (-3.1A) NAD A1227 (-3.3A) NAD A1227 ( 4.0A) NAD A1227 (-3.7A) None	1.11A	4qw0H-1og3A: undetectable 4qw0I-1og3A: undetectable	4qw0H-1og3A: 22.90 4qw0I-1og3A: 25.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QW0_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	1og3	T-CELL ECTO-ADP-RIBOSYLTRAN SFERASE 2 (Rattus norvegicus)	5 / 11	SER A 147 GLN A 144 ALA A 155 GLY A 127 THR A 128	NAD A1227 (-3.1A) NAD A1227 (-3.3A) NAD A1227 ( 4.0A) NAD A1227 (-3.7A) None	1.11A	4qw0V-1og3A: undetectable 4qw0W-1og3A: undetectable	4qw0V-1og3A: 22.90 4qw0W-1og3A: 25.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QW1_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	1og3	T-CELL ECTO-ADP-RIBOSYLTRAN SFERASE 2 (Rattus norvegicus)	5 / 12	SER A 147 GLN A 144 ALA A 155 GLY A 127 THR A 128	NAD A1227 (-3.1A) NAD A1227 (-3.3A) NAD A1227 ( 4.0A) NAD A1227 (-3.7A) None	1.10A	4qw1H-1og3A: undetectable 4qw1I-1og3A: undetectable	4qw1H-1og3A: 22.90 4qw1I-1og3A: 25.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QW1_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	1og3	T-CELL ECTO-ADP-RIBOSYLTRAN SFERASE 2 (Rattus norvegicus)	5 / 12	SER A 147 GLN A 144 ALA A 155 GLY A 127 THR A 128	NAD A1227 (-3.1A) NAD A1227 (-3.3A) NAD A1227 ( 4.0A) NAD A1227 (-3.7A) None	1.10A	4qw1V-1og3A: undetectable 4qw1W-1og3A: undetectable	4qw1V-1og3A: 22.90 4qw1W-1og3A: 25.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4UCI_B_ADNB2415_1 (RNA-DIRECTED RNA POLYMERASE L)	1og3	T-CELL ECTO-ADP-RIBOSYLTRAN SFERASE 2 (Rattus norvegicus)	4 / 7	PHE A 93 LYS A 103 TYR A 102 HIS A 101	None	1.41A	4uciB-1og3A: 0.0	4uciB-1og3A: 17.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4WCX_C_SAMC503_0 (BIOTIN AND THIAMIN SYNTHESIS ASSOCIATED)	1og3	T-CELL ECTO-ADP-RIBOSYLTRAN SFERASE 2 (Rattus norvegicus)	5 / 12	GLU A 196 LEU A 116 PRO A 64 ALA A 74 HIS A 71	None	1.20A	4wcxC-1og3A: undetectable	4wcxC-1og3A: 19.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5CZ7_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	1og3	T-CELL ECTO-ADP-RIBOSYLTRAN SFERASE 2 (Rattus norvegicus)	5 / 12	SER A 147 GLN A 144 ALA A 155 GLY A 127 THR A 128	NAD A1227 (-3.1A) NAD A1227 (-3.3A) NAD A1227 ( 4.0A) NAD A1227 (-3.7A) None	1.09A	5cz7V-1og3A: undetectable 5cz7W-1og3A: undetectable	5cz7V-1og3A: 22.90 5cz7W-1og3A: 25.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5D0X_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2)	1og3	T-CELL ECTO-ADP-RIBOSYLTRAN SFERASE 2 (Rattus norvegicus)	5 / 11	SER A 147 GLN A 144 ALA A 155 GLY A 127 THR A 128	NAD A1227 (-3.1A) NAD A1227 (-3.3A) NAD A1227 ( 4.0A) NAD A1227 (-3.7A) None	1.08A	5d0xV-1og3A: undetectable	5d0xV-1og3A: 22.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6J21_A_GBQA1201_0 (SUBSTANCE-P RECEPTOR,ENDOLYSIN)	1og3	T-CELL ECTO-ADP-RIBOSYLTRAN SFERASE 2 (Rattus norvegicus)	5 / 12	PRO A 193 ILE A 192 ILE A 178 HIS A 122 VAL A 124	None	1.37A	6j21A-1og3A: 0.0	6j21A-1og3A: 17.69

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1DDR_B_MTXB200_1","DIHYDROFOLATE REDUCTASE","1og3","T-CELL ECTO-ADP-RIBOSYLTRANSFERASE 2","Rattus norvegicus",5,"ALA A 104;ASP A  36;PHE A 100;ARG A  88;TYR A  18","None","1.11A","1ddrB-1og3A:undetectable","1ddrB-1og3A:23.32"],["1RMT_A_ADNA1501_1","CLASS B ACID PHOSPHATASE","1og3","T-CELL ECTO-ADP-RIBOSYLTRANSFERASE 2","Rattus norvegicus",5,"PHE A 142;TYR A 198;LEU A 211;THR A 128;ARG A 126","None;None;None;None;NAD A1227 (-3.2A)","1.46A","1rmtA-1og3A:0.0","1rmtA-1og3A:21.60"],["1TDR_A_MTXA170_1","TELLUROMETHIONYL DIHYDROFOLATE REDUCTASE","1og3","T-CELL ECTO-ADP-RIBOSYLTRANSFERASE 2","Rattus norvegicus",5,"ALA A 104;ASP A  36;PHE A 100;ARG A  88;TYR A  18","None","1.20A","1tdrA-1og3A:undetectable","1tdrA-1og3A:24.66"],["1X70_B_715B801_2","DIPEPTIDYL PEPTIDASE IV","1og3","T-CELL ECTO-ADP-RIBOSYLTRANSFERASE 2","Rattus norvegicus",3,"PHE A 145;TYR A  18;TYR A 107","None","1.05A","1x70B-1og3A:undetectable","1x70B-1og3A:15.23"],["1XVA_A_SAMA293_0","GLYCINE N-METHYLTRANSFERASE","1og3","T-CELL ECTO-ADP-RIBOSYLTRANSFERASE 2","Rattus norvegicus",5,"THR A 146;VAL A  90;SER A 219;GLY A 175;TYR A 198","None","1.38A","1xvaA-1og3A:undetectable","1xvaA-1og3A:22.01"],["2C8A_A_NCAA1252_0","MONO-ADP-RIBOSYLTRANSFERASE C3","1og3","T-CELL ECTO-ADP-RIBOSYLTRANSFERASE 2","Rattus norvegicus",4,"SER A 147;SER A 149;PHE A 160;GLN A 187","NAD A1227 (-3.1A);None;NAD A1227 (-3.4A);NAD A1227 (-3.9A)","1.25A","2c8aA-1og3A:11.4","2c8aA-1og3A:20.87"],["3WRK_D_CAMD502_0","CAMPHOR 5-MONOOXYGENASE","1og3","T-CELL ECTO-ADP-RIBOSYLTRANSFERASE 2","Rattus norvegicus",4,"LEU A 113;GLY A 175;THR A 172;VAL A 124","None","0.93A","3wrkD-1og3A:undetectable","3wrkD-1og3A:19.15"],["4EM2_A_SALA504_1","UNCHARACTERIZED HTH-TYPE TRANSCRIPTIONAL REGULATOR SAR2349","1og3","T-CELL ECTO-ADP-RIBOSYLTRANSFERASE 2","Rattus norvegicus",4,"PHE A  67;GLY A  72;LEU A  75;ILE A  57","None","0.80A","4em2A-1og3A:undetectable","4em2A-1og3A:20.18"],["4OTW_A_DB8A1101_2","RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3","1og3","T-CELL ECTO-ADP-RIBOSYLTRANSFERASE 2","Rattus norvegicus",3,"LEU A  75;LEU A  43;ASN A  87","None;None;NAD A1227 (-4.5A)","0.68A","4otwA-1og3A:undetectable","4otwA-1og3A:20.96"],["4QVP_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","1og3","T-CELL ECTO-ADP-RIBOSYLTRANSFERASE 2","Rattus norvegicus",5,"SER A 147;GLN A 144;ALA A 155;GLY A 127;THR A 128","NAD A1227 (-3.1A);NAD A1227 (-3.3A);NAD A1227 ( 4.0A);NAD A1227 (-3.7A);None","1.09A","4qvpH-1og3A:undetectable;4qvpI-1og3A:undetectable","4qvpH-1og3A:22.90;4qvpI-1og3A:25.00"],["4QVP_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","1og3","T-CELL ECTO-ADP-RIBOSYLTRANSFERASE 2","Rattus norvegicus",5,"SER A 147;GLN A 144;ALA A 155;GLY A 127;THR A 128","NAD A1227 (-3.1A);NAD A1227 (-3.3A);NAD A1227 ( 4.0A);NAD A1227 (-3.7A);None","1.09A","4qvpV-1og3A:undetectable;4qvpW-1og3A:undetectable","4qvpV-1og3A:22.90;4qvpW-1og3A:25.00"],["4QVV_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2","1og3","T-CELL ECTO-ADP-RIBOSYLTRANSFERASE 2","Rattus norvegicus",5,"SER A 147;GLN A 144;ALA A 155;GLY A 127;THR A 128","NAD A1227 (-3.1A);NAD A1227 (-3.3A);NAD A1227 ( 4.0A);NAD A1227 (-3.7A);None","1.16A","4qvvH-1og3A:undetectable","4qvvH-1og3A:22.90"],["4QVV_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2","1og3","T-CELL ECTO-ADP-RIBOSYLTRANSFERASE 2","Rattus norvegicus",5,"SER A 147;THR A 146;GLN A 144;ALA A 155;GLY A 127","NAD A1227 (-3.1A);None;NAD A1227 (-3.3A);NAD A1227 ( 4.0A);NAD A1227 (-3.7A)","0.97A","4qvvH-1og3A:undetectable","4qvvH-1og3A:22.90"],["4QVV_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2","1og3","T-CELL ECTO-ADP-RIBOSYLTRANSFERASE 2","Rattus norvegicus",5,"SER A 147;GLN A 144;ALA A 155;GLY A 127;THR A 128","NAD A1227 (-3.1A);NAD A1227 (-3.3A);NAD A1227 ( 4.0A);NAD A1227 (-3.7A);None","1.16A","4qvvV-1og3A:undetectable","4qvvV-1og3A:22.90"],["4QVV_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2","1og3","T-CELL ECTO-ADP-RIBOSYLTRANSFERASE 2","Rattus norvegicus",5,"SER A 147;THR A 146;GLN A 144;ALA A 155;GLY A 127","NAD A1227 (-3.1A);None;NAD A1227 (-3.3A);NAD A1227 ( 4.0A);NAD A1227 (-3.7A)","0.96A","4qvvV-1og3A:undetectable","4qvvV-1og3A:22.90"],["4QVY_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2","1og3","T-CELL ECTO-ADP-RIBOSYLTRANSFERASE 2","Rattus norvegicus",5,"SER A 147;GLN A 144;ALA A 155;GLY A 127;THR A 128","NAD A1227 (-3.1A);NAD A1227 (-3.3A);NAD A1227 ( 4.0A);NAD A1227 (-3.7A);None","1.15A","4qvyH-1og3A:undetectable","4qvyH-1og3A:22.90"],["4QVY_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2","1og3","T-CELL ECTO-ADP-RIBOSYLTRANSFERASE 2","Rattus norvegicus",5,"SER A 147;THR A 146;GLN A 144;ALA A 155;GLY A 127","NAD A1227 (-3.1A);None;NAD A1227 (-3.3A);NAD A1227 ( 4.0A);NAD A1227 (-3.7A)","0.98A","4qvyH-1og3A:undetectable","4qvyH-1og3A:22.90"],["4QVY_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","1og3","T-CELL ECTO-ADP-RIBOSYLTRANSFERASE 2","Rattus norvegicus",5,"SER A 147;GLN A 144;ALA A 155;GLY A 127;THR A 128","NAD A1227 (-3.1A);NAD A1227 (-3.3A);NAD A1227 ( 4.0A);NAD A1227 (-3.7A);None","1.15A","4qvyV-1og3A:undetectable;4qvyW-1og3A:undetectable","4qvyV-1og3A:22.90;4qvyW-1og3A:25.00"],["4QW0_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","1og3","T-CELL ECTO-ADP-RIBOSYLTRANSFERASE 2","Rattus norvegicus",5,"SER A 147;GLN A 144;ALA A 155;GLY A 127;THR A 128","NAD A1227 (-3.1A);NAD A1227 (-3.3A);NAD A1227 ( 4.0A);NAD A1227 (-3.7A);None","1.11A","4qw0H-1og3A:undetectable;4qw0I-1og3A:undetectable","4qw0H-1og3A:22.90;4qw0I-1og3A:25.00"],["4QW0_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","1og3","T-CELL ECTO-ADP-RIBOSYLTRANSFERASE 2","Rattus norvegicus",5,"SER A 147;GLN A 144;ALA A 155;GLY A 127;THR A 128","NAD A1227 (-3.1A);NAD A1227 (-3.3A);NAD A1227 ( 4.0A);NAD A1227 (-3.7A);None","1.11A","4qw0V-1og3A:undetectable;4qw0W-1og3A:undetectable","4qw0V-1og3A:22.90;4qw0W-1og3A:25.00"],["4QW1_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","1og3","T-CELL ECTO-ADP-RIBOSYLTRANSFERASE 2","Rattus norvegicus",5,"SER A 147;GLN A 144;ALA A 155;GLY A 127;THR A 128","NAD A1227 (-3.1A);NAD A1227 (-3.3A);NAD A1227 ( 4.0A);NAD A1227 (-3.7A);None","1.10A","4qw1H-1og3A:undetectable;4qw1I-1og3A:undetectable","4qw1H-1og3A:22.90;4qw1I-1og3A:25.00"],["4QW1_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","1og3","T-CELL ECTO-ADP-RIBOSYLTRANSFERASE 2","Rattus norvegicus",5,"SER A 147;GLN A 144;ALA A 155;GLY A 127;THR A 128","NAD A1227 (-3.1A);NAD A1227 (-3.3A);NAD A1227 ( 4.0A);NAD A1227 (-3.7A);None","1.10A","4qw1V-1og3A:undetectable;4qw1W-1og3A:undetectable","4qw1V-1og3A:22.90;4qw1W-1og3A:25.00"],["4UCI_B_ADNB2415_1","RNA-DIRECTED RNA POLYMERASE L","1og3","T-CELL ECTO-ADP-RIBOSYLTRANSFERASE 2","Rattus norvegicus",4,"PHE A  93;LYS A 103;TYR A 102;HIS A 101","None","1.41A","4uciB-1og3A:0.0","4uciB-1og3A:17.42"],["4WCX_C_SAMC503_0","BIOTIN AND THIAMIN SYNTHESIS ASSOCIATED","1og3","T-CELL ECTO-ADP-RIBOSYLTRANSFERASE 2","Rattus norvegicus",5,"GLU A 196;LEU A 116;PRO A  64;ALA A  74;HIS A  71","None","1.20A","4wcxC-1og3A:undetectable","4wcxC-1og3A:19.01"],["5CZ7_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","1og3","T-CELL ECTO-ADP-RIBOSYLTRANSFERASE 2","Rattus norvegicus",5,"SER A 147;GLN A 144;ALA A 155;GLY A 127;THR A 128","NAD A1227 (-3.1A);NAD A1227 (-3.3A);NAD A1227 ( 4.0A);NAD A1227 (-3.7A);None","1.09A","5cz7V-1og3A:undetectable;5cz7W-1og3A:undetectable","5cz7V-1og3A:22.90;5cz7W-1og3A:25.00"],["5D0X_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2","1og3","T-CELL ECTO-ADP-RIBOSYLTRANSFERASE 2","Rattus norvegicus",5,"SER A 147;GLN A 144;ALA A 155;GLY A 127;THR A 128","NAD A1227 (-3.1A);NAD A1227 (-3.3A);NAD A1227 ( 4.0A);NAD A1227 (-3.7A);None","1.08A","5d0xV-1og3A:undetectable","5d0xV-1og3A:22.90"],["6J21_A_GBQA1201_0","SUBSTANCE-P RECEPTOR,ENDOLYSIN","1og3","T-CELL ECTO-ADP-RIBOSYLTRANSFERASE 2","Rattus norvegicus",5,"PRO A 193;ILE A 192;ILE A 178;HIS A 122;VAL A 124","None","1.37A","6j21A-1og3A:0.0","6j21A-1og3A:17.69"]]